Skip to main content
    C

    Chemours Co (CC)

    Official site

    BASIC MATERIALS • SPECIALTY CHEMICALS • NYSE

    $12.18
    -0.30 (-2.44%)

    Market Cap: $2.00B

    Last updated: Nov 17, 2026 at 4:16 PM ET

    Chemours Co (CC) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Chemours (CC) has a market cap of $2.00B and an enterprise value of $5.14B. Its net debt of $3.13B equals 156.72% of its market cap. Its trailing P/E of 16.7x is above its 10-year median of 11.0x.

    Total Valuation

    Enterprise value is 156.72% above the market cap, as debt exceeds cash.

    Market Cap$2.00B
    Enterprise Value$5.14B
    Latest price (Nov 17, 2026)$12.18

    Key Dates

    The next earnings report is expected on Feb 17, 2027, covering the quarter ending Dec 31, 2026. The last ex-dividend date was Nov 16, 2026.

    Next Earnings DateFeb 17, 2027 (expected)
    Last Earnings DateNov 2, 2026
    Last Ex-Dividend DateNov 16, 2026
    Next Payment DateDec 15, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.02% in the quarter ended Sep 30, 2026 and grew 0.38% a year over 2 years.

    Shares Outstanding150.53M
    Shares Change (YoY)+0.43%
    Shares Change (QoQ)+0.02%
    Share Count Growth (2Y CAGR)+0.38%

    Valuation Ratios

    Sales and book value multiples are 0.3x and 11.8x. Its year-end P/E ranged from 5.0x to 21.7x from 2016 to 2025.

    P/E Ratio16.7x
    Forward P/E13.8x
    P/S Ratio0.3x
    Forward P/S0.3x
    P/B Ratio11.8x
    P/TBV Ratio17.1x
    P/FCF Ratio8.7x
    P/OCF Ratio5.0x
    PEG Ratio0.5

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 6.9x EBITDA and 23.5x free cash flow.

    EV / Sales0.9x
    EV / EBITDA6.9x
    EV / EBIT13.3x
    EV / FCF23.5x

    Price Statistics

    The stock is up 3.28% over 52 weeks and trades 10.04% below its 50-day average.

    Beta (1Y)1.41
    52-Week Change+3.28%
    1-Month Change-2.85%
    3-Month Change-22.94%
    6-Month Change-43.71%
    5-Year Change-51.71%
    10-Year Change-17.65%
    Total Return (1Y)+6.25%
    Total Return (3Y CAGR)-21.26%
    Total Return (5Y CAGR)-14.98%
    Return vs SPY (1Y)+0.79%
    Max Drawdown (1Y)-56.02%
    Max Drawdown (3Y)-69.02%
    Sharpe Ratio (1Y)0.19
    Correlation with SPY (1Y)0.32
    50-Day Average$13.54
    200-Day Average$18.11
    52-Week Range$10.22 to $28.22
    RSI (14 Days)37.5
    Average Volume (20 Days)2.45M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.81x current liabilities, and total debt is 24.73x shareholder equity.

    Current Ratio1.81x
    Quick Ratio0.98x
    Debt / Equity24.73x
    Debt / EBITDA5.36x
    Debt / FCF18.17x
    Interest Coverage1.33x

    Returns and Efficiency

    Return on invested capital is 6.28% over the last 12 months, against a 5-year average of 6.11%.

    Return on Equity (ROE)-109.03%
    Return on Assets (ROA)-2.32%
    Return on Invested Capital (ROIC)6.28%
    Return on Capital Employed (ROCE)6.98%
    ROE (5Y Average)-13.76%
    ROA (5Y Average)1.65%
    ROIC (5Y Average)6.11%
    Asset Turnover0.79x
    Inventory Turnover3.39x
    Receivables Turnover6.39x
    Cash Conversion Cycle94 days

    Scores

    CC has an Altman Z-Score of 1.57, in the distress zone below 1.81, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.

    Altman Z-Score1.57
    Altman Z ZoneDistress
    Piotroski F-Score4 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $5.84B over the last 12 months is up 0.10% from the 12 months before.

    Revenue$5.84B
    Revenue Growth (YoY)+0.10%
    Gross Profit$884.00M
    Operating Income$36.00M
    Pretax Income$132.00M
    Net Income-$169.00M
    EBITDA$715.00M
    EBIT$385.00M
    Reported EPS (TTM)$0.73

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 2.13% of the $7.29B in total assets.

    Cash and Equivalents$698.00M
    Total Debt$3.83B
    Net Debt$3.13B
    Net Debt Per Share$20.83
    Working Capital$1.44B
    Shareholder Equity$155.00M
    Book Value Per Share$1.03
    Tangible Book Value$107.00M
    Tangible Book Per Share$0.71
    Total Assets$7.29B
    Total Liabilities$7.14B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $189.00M of capital spending, operating cash flow left $211.00M of free cash flow.

    Operating Cash Flow$400.00M
    Capital Expenditures$189.00M
    Free Cash Flow$211.00M
    FCF Per Share$1.40
    Depreciation and Amortization$330.00M
    Dividends Paid$54.00M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 0.62%, against a 5-year average of 4.47%.

    Gross Margin15.13%
    Operating Margin0.62%
    Pretax Margin2.26%
    Net Margin-2.89%
    EBITDA Margin12.24%
    EBIT Margin6.59%
    FCF Margin3.61%
    Gross Margin (5Y Average)20.42%
    Operating Margin (5Y Average)4.47%
    Net Margin (5Y Average)1.69%

    Growth

    Revenue fell 5.26% a year over 3 years, and EPS 37.56% a year.

    Revenue Growth (3Y CAGR)-5.26%
    Revenue Growth (5Y CAGR)+3.17%
    EPS Growth (3Y CAGR)-37.56%
    EPS Growth (5Y CAGR)-13.48%
    FCF Growth (3Y CAGR)-51.53%
    FCF Growth (5Y CAGR)-37.62%

    Revenue and profit by year

    Dividends and Yields

    CC pays out 76.36% of earnings as dividends.

    Dividend Per Share (Annual)$0.35
    Dividend Yield2.87%
    Payment ScheduleQuarterly
    Dividend Growth (3Y CAGR)-19.97%
    Dividend Growth (5Y CAGR)-12.51%
    Payout Ratio76.36%
    FCF Payout Ratio25.59%
    Earnings Yield5.99%
    FCF Yield11.51%
    Buyback Yield0.00%
    Shareholder Yield2.95%

    Full dividend history

    Peer Position

    Against 11 similar companies, CC has the 6th highest P/E.

    P/E Ratio16.7x vs 15.3x median
    P/S Ratio0.3x vs 1.1x median
    ROIC6.28% vs 6.32% median
    Revenue Growth (Trailing 4 Quarters, YoY)+0.10% vs +8.27% median
    Dividend Yield2.87% vs 1.62% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 2.79% and EPS growth at 33.98% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+2.79%
    EPS Growth Forecast (2Y CAGR)+33.98%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About CC

    What is CC's market cap?

    Chemours has a market cap of $2.00B. Its enterprise value, which adds debt and subtracts cash, is $5.14B.

    What is CC's P/E ratio?

    Chemours has a trailing P/E ratio of 16.7x and a forward P/E of 13.8x.

    How many shares of CC are outstanding?

    Chemours has 150.53M shares outstanding. The count is up 0.43% from a year earlier.

    Does CC pay a dividend?

    Yes. Chemours pays $0.35 a share a year, a dividend yield of 2.87%.

    How much debt does CC have?

    Chemours has $3.83B of total debt and $698.00M of cash and equivalents, a net debt position of $3.13B.